Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2 studies found for:    3125434 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Withdrawn The Insulin Independence Trial (IIT) Evaluating the Safety and Efficacy of Oral Cyclosporine and Oral Lansoprazole for Insulin Independence Among Patients With Existing Type 1 Diabetes
Condition: Type 1 Diabetes
Interventions: Drug: Oral Cyclosporine and Oral Lansoprazole;   Drug: Placebos
2 Withdrawn The Insulin Independence Trial (IIT) Evaluating the Safety and Efficacy of Oral Cyclosporine and Oral Omeprazole for Insulin Independence Among Recent Onset Type 1 Diabetes Patients
Condition: Type 1 Diabetes
Interventions: Drug: Oral Cyclosporine and Oral Omeprazole;   Drug: Oral Omeprazole

Indicates status has not been verified in more than two years